| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-OLIG1 (180-271) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
OLIG1 |
| Gene ID: |
116448 |
| Uniprot ID: |
OLIG1_HUMAN |
| Immunogen Region: |
180-271 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 180-271 of human Olig1 (NP_620450.2). |
| Immunogen Sequence: |
GPAAPRLLLAGLPLLAAAPG SVLLAPGAVGPPDALRPAKY LSLALDEPPCGQFALPGGGA GGPGLCTCAVCKFPHLVPAS LGLAAVQAQFSK |
| Tissue Specificity | Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas is highly variable. |
| Function | Promotes formation and maturation of oligodendrocytes, especially within the brain. Cooperates with OLIG2 to establish the pMN domain of the embryonic neural tube. |
| Protein Name | Oligodendrocyte Transcription Factor 1Oligo1Class B Basic Helix-Loop-Helix Protein 6Bhlhb6Class E Basic Helix-Loop-Helix Protein 21Bhlhe21 |
| Cellular Localisation | Nucleus |
| Alternative Antibody Names | Anti-Oligodendrocyte Transcription Factor 1 antibodyAnti-Oligo1 antibodyAnti-Class B Basic Helix-Loop-Helix Protein 6 antibodyAnti-Bhlhb6 antibodyAnti-Class E Basic Helix-Loop-Helix Protein 21 antibodyAnti-Bhlhe21 antibodyAnti-OLIG1 antibodyAnti-BHLHB6 antibodyAnti-BHLHE21 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
